Inoue T, Honda M, Kawamura K, Tsuchiya K, Suzuki T, Ito K, Matsubara R, Shinohara K, Ishikane T, Sasaki K, Boku S, Fujisawa D, Ono Y, Koyama T:"Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.", Prog Neuropsychopharmacol Biol Psychiatry.38, 223-227, (2012)*
Inoue T, Tanaka T, Nakagawa S, Nakato Y, Kameyama R, Boku S, Toda H, Kurita T, Koyama T:"Utility and limitations of PHQ-9 in a clinic specializing in psychiatric care.",BMC Psychiatry.12, 73, (2012)*
Kohno K, Hoaki N, Inoue T, Nakai Y, Toyomaki A, Yasuo Araki Y, Hatano K, Terao T:"Latitude Effect on Bipolar Temperaments.",J Affect Disord.142, 53-56, (2012)*
Masuda T, Nakagawa S, Boku S, Nishikawa H, Takamura N, Kato A, Inoue T, Koyama T:"Noradrenaline increases neural precursor cells derived from adult rat dentate gyrus through beta2 receptor.",Prog Neuropsychopharmacol Biol Psychiatr.36, 44-51, (2012)*
Song N, Nakagawa S, Izumi T, Toda H, Kato A, Boku S, Inoue T, Sakagami H, Li X, Koyama T:“Involvement of CaMKIV in neurogenic effect with chronic fluoxetine treatment.",The International Journal of Neuropsychopharmacology.14, 1-10, (2012)
Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kato A, Kusumi I, Koyama T:"Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats.",Neuropsychiatr dis treat.8, 501-507, (2012)*
Kitaichi Y, Inoue T, Nakagawa S, Boku S, Koyama T:“Effects of combined treatment with clorgyline and selegiline on extracellular noradrenaline and serotonin levels.",Acta Neuropsychiatrica.24(6), 369-373, (2012)*
Boku S, Nakagawa S, Toda H, Kato A, Takamura N, Omiya Y, Inoue T, Koyama T: "ROCK2 regulates bFGF-induced proliferation of SH-SY5Y cells through GSK-3β and β-catenin pathway.",Brain Res.1492, 7-17, (2013)*
Izumi T, Boku S, Shinmin W, Inoue T, Konno K, Yamaguchi T, Yoshida T, Matsumoto M, Watanabe M, Koyama T, Yoshioka M:"Retrieval of conditioned fear activates the basolateral and intercalated nucleus of amygdala.",J Neurosci Res.89, 773-790, (2011)*
Song N, Boku S, Nakagawa S, Kato A, Toda H, Takamura N, Omiya Y, Kitaichi Y, Inoue T, Koyama T:"Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells.", Prog Neuropsychopharmacol Biol Psychiatry.38, 183-189, (2012)*
Tsutsui K, Kanbayashi T, Tanaka K, Boku S, et al:"Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.", BMC psychiatry.12, 37, (2012)*
Takamura N, Masuda T, Inoue T, Nakagawa S, Koyama T:"The effects of the co-administration of the α1-adrenoreceptor antagonist prazosin on the anxiolytic effect of citalopram in conditioned fear stress in the rat.", Prog Neuropsychopharmacol Biol Psychiatry.39, 107-111, (2012)*
Miyajima M, Toyomaki A, Hashimoto N, Kusumi I, Murohashi H, Koyama T:"Discrepancy of neural response between exogenous and endogenous task switching: an event-related potentials study", Neuroreport.23(11):August 1, 642-646, (2012)*
2. Case report
Sakurai K, Kurita T, Shiga T, Takeda Y:“A patient who misidentified all surrounding persons as her family",Epilepsy Behav.25, 162-165, (2012)*
Sakurai K, Shiga T, Kurita T, Takeda Y, Tamaki N, Koyama T:“SPECT findings during simple partial statusepilepticus", Neurology Asia.17, 147-151, (2012)*
Matsuda N, Hashimoto N, Kusumi I, Ito K, Koyama T:"Tardive laryngeal dystonia associated with aripiprazole monotherapy.", J Clin Psychopharmacol.Apr.32(2), 297-298, (2012)
3. Review article
Hiroi N, Hiramoto T, Harper KM, Suzuki G, Boku S:"Mouse models of 22q11.2-associated autism spectrum disorder.", Autism:S1-001,, (2012)
Toyomaki A, Murohashi H:"Salience network"dysfunction hypothesis in autism spectrum disorders.", Japanese Psychological Research.55(2),, (2013)
